184 related articles for article (PubMed ID: 38776611)
1. Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients.
Wan T; Garland SJ; Drury CT; Lambert J; Yoon J; Chan M
Thromb Res; 2024 Jul; 239():109036. PubMed ID: 38776611
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic outcomes with appropriate or partial prophylaxis.
Amin AN; Lin J; Johnson BH; Schulman KL
Thromb Res; 2010 Jun; 125(6):513-7. PubMed ID: 19931121
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized Patients.
Mason SW; Barber A; Jones E; Chen SL; Moll S; Northam K
Am J Med; 2020 Jun; 133(6):e249-e259. PubMed ID: 31862336
[TBL] [Abstract][Full Text] [Related]
4. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
[TBL] [Abstract][Full Text] [Related]
5. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
6. Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.
Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah BR
Am J Cardiovasc Drugs; 2021 Jul; 21(4):443-452. PubMed ID: 33313988
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
[TBL] [Abstract][Full Text] [Related]
8. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.
Dobesh PP; Trujillo TC; Finks SW
Pharmacotherapy; 2013 Jun; 33(6):650-64. PubMed ID: 23553464
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.
Shorr AF; Sarnes MW; Peeples PJ; Stanford RH; Happe LE; Farrelly E
Am J Health Syst Pharm; 2007 Nov; 64(22):2349-55. PubMed ID: 17989444
[TBL] [Abstract][Full Text] [Related]
10. Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.
Novo-Veleiro I; Alvela-Suárez L; Costa-Grille A; Suárez-Dono J; Ferrón-Vidan F; Pose-Reino A
BMJ Open; 2018 May; 8(5):e021288. PubMed ID: 29764885
[TBL] [Abstract][Full Text] [Related]
11. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.
Zeidan AM; Streiff MB; Lau BD; Ahmed SR; Kraus PS; Hobson DB; Carolan H; Lambrianidi C; Horn PB; Shermock KM; Tinoco G; Siddiqui S; Haut ER
Am J Hematol; 2013 Jul; 88(7):545-9. PubMed ID: 23553743
[TBL] [Abstract][Full Text] [Related]
12. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
13. "Leaning" the process of venous thromboembolism prophylaxis.
Biffl WL; Beno M; Goodman P; Bahia A; Sabel A; Snow K; Steele AW; Swartwood C; Thienelt C; MacKenzie TD; Mehler PS
Jt Comm J Qual Patient Saf; 2011 Mar; 37(3):99-109. PubMed ID: 21500752
[TBL] [Abstract][Full Text] [Related]
14. Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
Spyropoulos AC; Preblick R; Kwong WJ; Lingohr-Smith M; Lin J
Clin Appl Thromb Hemost; 2017 Sep; 23(6):532-541. PubMed ID: 27899520
[TBL] [Abstract][Full Text] [Related]
15. A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.
Le P; Martinez KA; Pappas MA; Rothberg MB
J Thromb Haemost; 2017 Jun; 15(6):1132-1141. PubMed ID: 28371250
[TBL] [Abstract][Full Text] [Related]
16. Short-term therapy with enoxaparin or unfractionated heparin for venous thromboembolism in hospitalized patients: utilization study and cost-minimization analysis.
Argenta C; Ferreira MA; Sander GB; Moreira LB
Value Health; 2011; 14(5 Suppl 1):S89-92. PubMed ID: 21839908
[TBL] [Abstract][Full Text] [Related]
17. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of venous thromboembolism in the elderly patient.
Tincani E; Crowther MA; Turrini F; Prisco D
Clin Interv Aging; 2007; 2(2):237-46. PubMed ID: 18044139
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
